Insiders 10x Genomics, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:32:57 2024-05-06 am EDT			5-day change	1st Jan Change
27.58 ^USD	+0.35%		-2.64%	-50.59%

May. 02	North American Morning Briefing : Stock Futures -2-	DJ
May. 01	UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating	MT

James Wilbur to Depart from 10X Genomics, Inc. as Chief Commercial Officer, Effective from February 1, 2024	Jan. 16	CI
10x Genomics Insider Sold Shares Worth $619,494, According to a Recent SEC Filing	Nov. 22	MT
Insider Sell: 10x Genomics	23-08-24	MT
Insider Sell: 10x Genomics	23-08-24	MT
Insider Sell: 10x Genomics	23-08-24	MT
Insider Sell: 10x Genomics	23-08-16	MT
Insider Sell: 10x Genomics	23-08-03	MT
Insider Sell: 10x Genomics	23-07-21	MT
Insider Sell: 10x Genomics	23-07-21	MT
10X Genomics, Inc. Announces Board Changes	23-07-20	CI
Insider Sell: 10x Genomics	23-06-16	MT
Insider Sell: 10x Genomics	23-05-25	MT
Insider Sell: 10x Genomics	23-05-15	MT
10x Genomics Hires Jim Wilbur as Chief Commercial Officer	22-07-14	MT
10X Genomics, Inc. Appoints Jim Wilbur as Chief Commercial Officer, Effective July 27,2022	22-07-14	CI
Insider Sell: 10x Genomics	22-02-18	MT
Insider Sell: 10x Genomics	22-02-11	MT
Insider Sell: 10x Genomics	22-01-14	MT
Insider Sell: 10x Genomics	22-01-07	MT
Insider Sell: 10x Genomics	22-01-05	MT

No results for this search